Bowhead Specialty (BOW) Competitors $33.85 +0.60 (+1.82%) Closing price 07/14/2025 03:59 PM EasternExtended Trading$33.83 -0.03 (-0.09%) As of 07/14/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BOW vs. FG, OSCR, PLMR, GSHD, HGTY, NMIH, LMND, BHF, CS, and ALHCShould you be buying Bowhead Specialty stock or one of its competitors? The main competitors of Bowhead Specialty include F&G Annuities & Life (FG), Oscar Health (OSCR), Palomar (PLMR), Goosehead Insurance (GSHD), Hagerty (HGTY), NMI (NMIH), Lemonade (LMND), Brighthouse Financial (BHF), Credit Suisse Group (CS), and Alignment Healthcare (ALHC). These companies are all part of the "insurance" industry. Bowhead Specialty vs. Its Competitors F&G Annuities & Life Oscar Health Palomar Goosehead Insurance Hagerty NMI Lemonade Brighthouse Financial Credit Suisse Group Alignment Healthcare Bowhead Specialty (NYSE:BOW) and F&G Annuities & Life (NYSE:FG) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations, media sentiment and institutional ownership. Which has higher earnings & valuation, BOW or FG? F&G Annuities & Life has higher revenue and earnings than Bowhead Specialty. F&G Annuities & Life is trading at a lower price-to-earnings ratio than Bowhead Specialty, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBowhead Specialty$425.66M2.61$38.24M$1.3125.84F&G Annuities & Life$5.74B0.72$639M$3.778.16 Do analysts recommend BOW or FG? Bowhead Specialty currently has a consensus target price of $39.67, suggesting a potential upside of 17.17%. F&G Annuities & Life has a consensus target price of $43.33, suggesting a potential upside of 40.93%. Given F&G Annuities & Life's higher possible upside, analysts plainly believe F&G Annuities & Life is more favorable than Bowhead Specialty.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bowhead Specialty 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67F&G Annuities & Life 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media refer more to BOW or FG? In the previous week, F&G Annuities & Life had 1 more articles in the media than Bowhead Specialty. MarketBeat recorded 5 mentions for F&G Annuities & Life and 4 mentions for Bowhead Specialty. F&G Annuities & Life's average media sentiment score of 0.07 beat Bowhead Specialty's score of 0.00 indicating that F&G Annuities & Life is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bowhead Specialty 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral F&G Annuities & Life 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, BOW or FG? Bowhead Specialty has a beta of -0.6, suggesting that its share price is 160% less volatile than the S&P 500. Comparatively, F&G Annuities & Life has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Is BOW or FG more profitable? F&G Annuities & Life has a net margin of 9.90% compared to Bowhead Specialty's net margin of 9.32%. F&G Annuities & Life's return on equity of 12.89% beat Bowhead Specialty's return on equity.Company Net Margins Return on Equity Return on Assets Bowhead Specialty9.32% 12.52% 2.89% F&G Annuities & Life 9.90%12.89%0.65% Do insiders and institutionals hold more shares of BOW or FG? 95.9% of F&G Annuities & Life shares are held by institutional investors. 2.1% of F&G Annuities & Life shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryF&G Annuities & Life beats Bowhead Specialty on 11 of the 16 factors compared between the two stocks. Get Bowhead Specialty News Delivered to You Automatically Sign up to receive the latest news and ratings for BOW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BOW vs. The Competition Export to ExcelMetricBowhead SpecialtyINS IndustryFinance SectorNYSE ExchangeMarket Cap$1.11B$56.36B$12.03B$20.67BDividend YieldN/A2.01%5.54%3.71%P/E Ratio25.8417.8019.2927.86Price / Sales2.612.6726.0356.13Price / Cash25.2328.8118.5517.92Price / Book2.993.022.294.60Net Income$38.24M$4.66B$992.75M$989.89M7 Day Performance-3.19%-0.84%0.52%0.43%1 Month Performance-6.89%-0.64%4.38%5.50%1 Year Performance24.83%23.99%538.82%9.92% Bowhead Specialty Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BOWBowhead Specialty2.232 of 5 stars$33.85+1.8%$39.67+17.2%+30.4%$1.11B$425.66M25.84193FGF&G Annuities & Life4.3716 of 5 stars$31.19-4.1%$43.33+38.9%-26.6%$4.38B$5.74B8.271,338News CoverageAnalyst DowngradeOSCROscar Health1.5219 of 5 stars$16.79+1.9%$16.58-1.2%-8.2%$4.19B$9.18B59.962,400Analyst ForecastHigh Trading VolumePLMRPalomar3.0197 of 5 stars$145.32-1.6%$174.17+19.9%+64.8%$3.95B$553.86M29.01150Positive NewsGSHDGoosehead Insurance3.9164 of 5 stars$100.60-3.7%$115.40+14.7%+58.3%$3.92B$314.51M84.541,580HGTYHagerty1.0476 of 5 stars$10.16-0.3%$10.50+3.3%-8.8%$3.48B$1.20B50.801,744NMIHNMI2.9025 of 5 stars$41.19-4.5%$42.43+3.0%+7.4%$3.37B$650.97M8.90234Analyst DowngradeLMNDLemonade2.3098 of 5 stars$42.62+0.3%$30.17-29.2%+105.6%$3.11B$526.50M-14.021,235News CoverageAnalyst ForecastBHFBrighthouse Financial4.6063 of 5 stars$50.70-4.9%$59.70+17.8%+2.3%$3.06B$4.72B6.081,400Analyst ForecastCSCredit Suisse GroupN/A$0.89flatN/AN/A$2.77B$22.88B1.3750,480ALHCAlignment Healthcare2.3952 of 5 stars$13.14-3.2%$17.17+30.6%+51.1%$2.68B$2.70B-27.381,679 Related Companies and Tools Related Companies F&G Annuities & Life Alternatives Oscar Health Alternatives Palomar Alternatives Goosehead Insurance Alternatives Hagerty Alternatives NMI Alternatives Lemonade Alternatives Brighthouse Financial Alternatives Credit Suisse Group Alternatives Alignment Healthcare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BOW) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bowhead Specialty Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bowhead Specialty With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
